Robert Gardner Harrison - 10 Jan 2025 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Jan 2025, 21:12:55 UTC
Prior SEC filing
12 Nov 2024
Next SEC filing
13 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Benjamin G. Jackson, Attorney-in-fact

Key filing fact

Robert Gardner Harrison filed Form 4 for SERA PROGNOSTICS, INC. (SERA) on 14 Jan 2025.

Key facts

  • This page summarizes Robert Gardner Harrison's Form 4 filing for SERA PROGNOSTICS, INC. (SERA).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Jan 2025, 21:12.

Change

  • Previous filing in this sequence was filed on 12 Nov 2024.
  • Current net transaction value: -$119,678.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SERA transaction

Class A Common Stock

Sale

Transaction value
$90,316
Shares
-12,372
Change %
-9.4%
Price
$7.30
Shares after
118,674
Date
10 Jan 2025
Ownership
Direct
Footnotes
F1, F2
SERA transaction

Class A Common Stock

Sale

Transaction value
$14,714
Shares
-1,837
Change %
-1.5%
Price
$8.01
Shares after
116,837
Date
10 Jan 2025
Ownership
Direct
Footnotes
F1, F3
SERA transaction

Class A Common Stock

Sale

Transaction value
$14,648
Shares
-2,264
Change %
-1.9%
Price
$6.47
Shares after
114,573
Date
13 Jan 2025
Ownership
Direct
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2024.

Footnote F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.93 to $7.92, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Footnote F3

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.93 to $8.13, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Footnote F4

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.16 to $6.74, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .